Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-05-08 12:42 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162.50
-500 vol $0.325 each |
111,383 | |
Filed 2023-05-08 12:37 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,725
-13,500 vol $0.35 each |
90,883 | |
Filed 2023-05-08 12:37 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,725
-5,000 vol $0.345 each |
104,383 | |
Filed 2023-05-08 12:36 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-680.00
-2,000 vol $0.34 each |
109,383 | |
Filed 2023-05-08 12:36 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-250,000
-500 vol $500.00 each |
||
Filed 2023-05-08 12:35 Tx date 2023-05-08 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,845
-29,000 vol $0.305 each |
111,883 | |
Filed 2022-09-14 14:56 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,940,000 vol |
60,000 | |
Filed 2022-09-14 14:55 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,903,242 vol |
140,883 | |
Filed 2022-03-29 22:38 Tx date 2022-03-21 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+2,550,000 vol |
7,044,125 | |
Filed 2022-03-29 22:38 Tx date 2022-03-21 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Emerald Baron, LLC (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-2,550,000 vol |
0 | |
Filed 2022-03-29 22:36 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
$-876,354.375
-4,494,125 vol $0.195 each |
0 | |
Filed 2022-03-29 22:35 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+4,494,125 vol |
4,494,125 | |
Filed 2022-03-29 22:34 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 22:34 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
$876,354
+4,494,125 vol $0.195 each |
4,494,125 | |
Filed 2022-03-29 22:31 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-30 12:40 Tx date 2020-09-16 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
3,000,000 | |
Filed 2020-11-30 12:37 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-30 12:36 Tx date 2020-05-11 |
$MYCO
Mydecine Innovations Group Inc. |
Michaels, Damon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Emerald Baron, LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,550,000 |